The Latest Cardiac and Vascular News
Data presented at EuroPCR 2022 reinforce the impact of Abbott’s minimally invasive heart devices on patient outcomes and quality of life Findings demonstrate TriClip™ transcatheter edge-to-edge (TEER) repair is effective at reducing tricuspid regurgitation across a broad range of anatomies One-year outcomes for Navitor™ transcatheter aortic valve implantation (TAVI) system […]
Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today […]
Erin Enright and Alfonso “Chito” Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with the Company’s Strategy Per Wold-Olsen Named Chairman of the Board David Stack and Joe Zakrzewski to Retire from the Board Actions Reflect Company and Board’s Commitment to Ongoing Refreshment and […]
BEAUFORT, S.C.–(BUSINESS WIRE)–Research published by THE SAGE GROUP examines PAD disparities in African Americans and the contributing factors, as well as quantifies PAD prevalence in AA. “While it is well known that African Americans have a higher prevalence of PAD, prior to this publication, there were no estimates of the […]
WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA® Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access […]
Sales Funnel Increases 9% and System Trials Increases 5% Month Over Month First Quarter Revenue of $3.2 Million an Increase of 100% Year Over Year SUWANEE, GA, May 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – On May 17, 2022, SANUWAVE Health, Inc. (OTC:PINK: SNWV), a leading provider of next-generation wound care […]
LEXINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced results from a preclinical […]
XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT – Data from the Phase 1 dose-escalation portion of the Phase 1/2 EXACT study demonstrate XC001 was well-tolerated at all dose […]
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale […]
SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced the appointment of Janice Lu, M.D., Ph.D., as Chief Medical Officer of Ambrx. Dr. Lu is a distinguished clinical professor of […]
